Z3 Biocommunications

Z3 Biocommunications is a private life science communications and investor relations consultancy serving biotech and healthcare companies. The firm positions itself around strategic and crisis communications, IR support, and research and translation services that help translate scientific and clinical progress for investors and other stakeholders. Its business appears to center on corporate communications advisory rather than drug discovery or therapeutic product development. Publicly available information indicates the company is based in New Haven, Connecticut and has operated since 2018. Z3 Biocommunications has been listed as the investor and company contact for biotech issuers, consistent with an outsourced IR and communications support model.